Position in RPRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,977,800,283
+$298,575,128 QoQ
Shares Held
35,273,770
+0.8% QoQ
Ownership
6.13%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#2
of 646 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. RPRX ranks #2 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,695,144 | $2,332,218,879 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
35,273,770 | $1,977,800,283 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,210,221 | $1,199,786,678 | |
| 4 | INSM |
INSMED Inc
|
8,238,124 | $878,348,780 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,988,614 | $530,403,126 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,361,639 | $142,548,530 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
2,963,410 | $139,398,806 | |
| 8 | COAG |
Hemab Therapeutics Holdings, Inc.
|
3,603,876 | $132,370,365 |
All Filings in RPRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,977,800,283 | 35,273,770 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,679,225,155 | 35,005,736 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,201,870,499 | 31,104,309 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $960,063,844 | 27,212,694 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $788,358,738 | 21,880,620 | Shares | Defined | 2025-08-13 | |
| 2023-03-31 | $138,043,504 | 3,831,349 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $151,407,443 | 3,831,160 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $200,833,381 | 4,998,342 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $209,973,278 | 4,994,607 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $194,550,266 | 4,993,590 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $198,803,361 | 4,988,792 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $180,247,057 | 4,987,467 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $694,481,600 | 16,942,708 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $717,509,785 | 16,449,101 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $823,390,217 | 16,451,353 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $436,435,989 | 10,374,043 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $395,054,020 | 8,137,055 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||